Introduction {#sec1-2055207620918715}
============

Obesity continues to be a major epidemic in the USA, affecting individuals across diverse demographics and spectrums.^[@bibr1-2055207620918715]^ The continued growth of the obesity epidemic is particularly concerning because obesity can have a physical, psychological, as well as social impact on one's well-being.^[@bibr2-2055207620918715]^ Obesity is also known to be associated with several significant health issues, such as hypertension,^[@bibr3-2055207620918715]^ sleep apnea,^[@bibr4-2055207620918715]^ type II diabetes,^[@bibr5-2055207620918715]^ cardiovascular disease,^[@bibr6-2055207620918715]^ and even mortality.^[@bibr7-2055207620918715]^ Consequently, it is critical to diagnose and document obesity accurately in the patient's electronic medical record (EMR), so that the information can be used and shared to improve clinical decision making, such as screening, prescribing, and identifying targeted therapies for treatment, and, in turn, to improve the patient's prognosis. Furthermore, proper documentation of diagnoses in an EMR^[@bibr8-2055207620918715]^ also allows for this information to be shared with the patient and other clinicians, thus encouraging collaborative practice.^[@bibr9-2055207620918715]^

Obesity is generally classified on the basis of the body mass index (BMI), calculated as the total body weight (in kilograms) divided by the height (in meters squared). According to the Centers for Disease Control, obesity is defined as a BMI ≥30 kg/m^2^, while a BMI of ≥40 kg/m^2^ is defined as class 3 obesity or morbid obesity.

The Centers for Medicare and Medicaid Services (CMS) Electronic Health Record Incentive Programs^[@bibr10-2055207620918715]^ allow health-care providers to become eligible for payments as an incentive for using an EMR system, or face penalty upon failure to adopt such a system. An integral component of the incentive program, Meaningful Use Stage 1, mandated the recording of height, weight, blood pressure, and BMI as core measures of vital signs in the EMR at each patient visit.^[@bibr11-2055207620918715]^

Besides documentation of individual body weight and height at each visit, most modern EMR systems also allow clinicians to maintain individual patients' problem lists, utilizing standardized terminologies such as the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM).^[@bibr12-2055207620918715]^ These problem lists serve as critical records to identify and remind clinicians quickly of the presenting patient's health issues. While they are part of modern EMR systems, these problem lists still require clinicians to update them manually by adding any new and current health problems while removing (or archiving) prior resolved health conditions.

Acknowledgment and subsequent diagnosis are the first steps toward addressing any health condition. Prior evidence reveals that increased use of the EMR is associated with the likelihood of the documentation of obesity in the patient's medical record.^[@bibr13-2055207620918715]^ Moreover, obese patients with documentation of obesity in their problem list are more likely to receive obesity treatment and management from their physicians.^[@bibr14-2055207620918715]^ Yet, obesity remains largely underdiagnosed^[@bibr15-2055207620918715]^ for several reasons, including the use of appearance rather than BMI for diagnosis,^[@bibr16-2055207620918715]^ lack of preventive care, weight stigma, and implicit anti-fat bias among clinicians.^[@bibr17-2055207620918715],[@bibr18-2055207620918715]^

Broader adoption of EMRs has given rise to the rapid collection of vast amounts of health data. This big data can be further harnessed by performing analytics to find patterns in the data and develop novel machine learning algorithms for use in clinical decision support. Prior evidence demonstrates the value attributed to the secondary use of these existing data to improve health quality and patient outcomes by the implementation of these models in clinical decision support.^[@bibr19-2055207620918715][@bibr20-2055207620918715]--[@bibr21-2055207620918715]^

Therefore, identifying the various factors that play a role in documenting obesity diagnosis and methods to improve current documentation practices deserves further investigation. This paper examines the extent of obesity-related problem list omissions at an academic outpatient clinic and identifies patient-specific factors associated with documentation of obesity in the EMR. We also discuss potential solutions and techniques to aid the maintenance of accurate and updated problem lists.

Method {#sec2-2055207620918715}
======

Study sample and inclusion criteria {#sec3-2055207620918715}
-----------------------------------

Institutional Review Board (IRB) approval (\#UMCIRB 15-000907) was obtained prior to commencing any study activities. We utilized a retrospective cross-sectional design to analyze the outpatient EMRs of patients at East Carolina University (ECU Physicians). ECU Physicians is the medical practice of the Brody School of Medicine, spread across 26 locations in Eastern North Carolina. Office visit summary data were extracted from the EMR for all adult patients (aged ≥18 years) who completed at least one office visit at any of the outpatient clinic locations at least once between January 1, 2017, and December 31, 2017, and had a corresponding BMI measure for the visit. Obese patients were identified using the BMI (≥30 kg/m^2^) which was recorded in the EMR for each office visit. For patients with more than one visit during the time period, the BMI from only the most recent visit was included for analysis in order to reflect their most recent BMI, consistent with their diagnosis state.

We subsequently extracted problem lists for the obese patients identified above to check for documentation of an obesity diagnosis in the EMR. Documentation of obesity in the problem list was identified using the corresponding ICD-10 category code (E66 and below). Patients with any history of any pregnancy-related diagnosis were identified using corresponding ICD-10 category codes O00 through O9A and excluded in order to avoid confounding the results. Finally, all the identified obese patients were categorized into two groups (diagnosed or undiagnosed) based on the presence of a documented diagnosis for obesity or its omission in the EMR problem list. [Figure 1](#fig1-2055207620918715){ref-type="fig"} illustrates the steps associated with the identification of the study sample and the gathering of the associated data.

![Steps for identification of study sample and categorization into study groups.](10.1177_2055207620918715-fig1){#fig1-2055207620918715}

The two groups were compared based on demographics (sex, age group, race and ethnicity, and insurance status) to assess which specific patient characteristics were associated with the documentation of obesity in the EMR.

We also compared the two groups based on the patients' use of the online patient portal. Prior evidence indicates that patients who have access to their medical records typically have more complete and accurate health information in the EMR, which is attributed to patient cross-checking and giving feedback on their health records.^[@bibr22-2055207620918715][@bibr23-2055207620918715]--[@bibr24-2055207620918715]^ Therefore, within our outpatient practice, we wanted to assess if obese patients who were patient portal users may have a more updated and accurate problem list than nonusers of the patient portal. A patient portal user was defined as any patient who had activated their patient portal account and had logged in to the patient portal at least once six months beyond the activation date.

Similarly, we compared the documentation of obesity among two groups based on their diagnosis of other associated comorbidities (coronary heart disease, type II diabetes, hyperlipidemia, hypertension, osteoarthritis, and sleep apnea) to assess whether they played a role in the documentation of obesity in the EMR. We selected these chronic health conditions because there is abundant empirical evidence indicating their association with obesity.^[@bibr17-2055207620918715],[@bibr25-2055207620918715][@bibr26-2055207620918715][@bibr27-2055207620918715]--[@bibr28-2055207620918715]^

Statistical analysis {#sec4-2055207620918715}
--------------------

We conducted nonparametric chi-square tests to assess the differences in the distribution of the sample between the two groups based on their demographics, patient portal use, and diagnosed comorbidities. We used logistic regression analysis to predict the likelihood of the presence or omission of a documented diagnosis for all obese patients. An α of 0.05 was used as the threshold level of significance. All statistical analyses were conducted using IBM SPSS Statistics for Windows v25.0. (IBM Corp., Armonk, NY).

Results {#sec5-2055207620918715}
=======

EMRs for 10,208 unique patients with an obesity BMI were included for analysis, of which 4119 (40%) did not have a corresponding diagnosis of obesity in the EMR problem list. [Table 1](#table1-2055207620918715){ref-type="table"} lists the distribution of the patients across the diagnosed and the undiagnosed groups by patient characteristics (obesity group, sex, age, race, patient portal use, and insurance provider). Chi-square analyses revealed statistically significant differences between the two groups for each of the patient characteristics assessed (80% for morbidly obese vs. 52% for obese patients; 62% for females vs. 55% for males; 66% for patients aged ≤65 years vs. 34% for patients aged ≥66 years; 65% for black patients vs. 55%, 54%, and 53% for Hispanic, other, and white patients, respectively; 62% for patient portal users vs. 59% for nonusers; and 61% of publicly insured vs. 59% and 56% for privately insured and uninsured).

###### 

Presence of obesity diagnosis in EMR problem list across various patient characteristics for obese patients (BMI ≥30 kg/m^2^).

![](10.1177_2055207620918715-table1)

  Patient characteristic              Obesity diagnosis present in EMR problem list (%)   Obesity diagnosis absent in EMR problem list (%)   *p*
  ----------------------------------- --------------------------------------------------- -------------------------------------------------- --------------
  *Obesity group*                                                                                                                            **\<0.0001**
   Obese (BMI 30--39 kg/m^2^)         3947 (52%)                                          3581 (48%)                                         
   Morbidly obese (BMI ≥40 kg/m^2^)   2142 (80%)                                          538 (20%)                                          
  *Sex*                                                                                                                                      **\<0.0001**
   Female                             4259 (62%)                                          2631 (38%)                                         
   Male                               1830 (55%)                                          1488 (45%)                                         
  *Age (years)*                                                                                                                              **\<0.0001**
   18--35                             1269 (64%)                                          713 (36%)                                          
   36--45                             1177 (67%)                                          591 (33%)                                          
   46--55                             1467 (67%)                                          723 (33%)                                          
   56--65                             1463 (68%)                                          692 (32%)                                          
   66--75                             545 (37%)                                           943 (63%)                                          
   76+                                168 (27%)                                           457 (73%)                                          
  *Race*                                                                                                                                     **\<0.0001**
   Black                              3854 (65%)                                          2114 (35%)                                         
   Hispanic                           77 (55%)                                            63 (45%)                                           
   Other                              78 (54%)                                            67 (46%)                                           
   White                              2080 (53%)                                          1875 (47%)                                         
  *Patient portal use*                                                                                                                       **\<0.0133**
   Users                              1787 (62%)                                          1116 (38%)                                         
   Nonusers                           4302 (59%)                                          3003 (41%)                                         
  *Insurance provider*                                                                                                                       **0.01805**
   Private                            3255 (59%)                                          2296 (41%)                                         
   Public                             2653 (61%)                                          1683 (39%)                                         
   Uninsured                          181 (56%)                                           140 (44%)                                          
  *Total*                             6089 (60%)                                          4119 (40%)                                         

Statistically significant values are shown in bold.

EMR: electronic medical record; BMI: body mass index.

Results of logistic regression analyses indicate that the patient characteristics assessed were predictive of the presence of an obesity diagnosis in the EMR problem list for all obese patients (inferred from BMI ≥30 kg/m^2^). As indicated by odds ratios (OR), obese patients who were female (OR=1.3), black (OR=1.6), and aged ≤65 years (OR=3.9) had higher odds of a presence of an obesity diagnosis in the EMR problem list compared to obese patients who were male, white, and aged ≥66 years. Additionally, morbidly obese patients (BMI ≥40 kg/m^2^) were far more likely to be diagnosed with obesity (OR=3.6) compared to other obese patients (BMI 30--39 kg/m^2^).

[Figure 2](#fig2-2055207620918715){ref-type="fig"} depicts the receiver-operating characteristic (ROC) curve, displaying the collective strength of the patient characteristics assessed in being able to predict the presence of an obesity diagnosis in the EMR for obese patients. The c-statistic for the ROC, which describes the area under the curve, was 0.713, indicating that patient characteristics can effectively discriminate^[@bibr29-2055207620918715]^ between the two study groups to predict whether an obese patient would have an obesity diagnosis documented in the EMR problem list.

![Receiver-operating characteristic curve based on patient characteristics as variables in predicting the presence of an obesity diagnosis in the electronic medical record problem list for obese patients (body mass index ≥30 kg/m^2^).](10.1177_2055207620918715-fig2){#fig2-2055207620918715}

We also assessed the presence of an obesity diagnosis in the EMR problem list for the two study groups based on the presence of diagnoses for other obesity-related comorbidities (coronary heart disease, type II diabetes, hyperlipidemia, hypertension, osteoarthritis, and sleep apnea; [Table 2](#table2-2055207620918715){ref-type="table"}). The results of a chi-square test indicated statistically significant differences among the two study groups based on the presence of some comorbidities (coronary heart disease, type II diabetes, hypertension, and sleep apnea). We found no significant differences for obese patients with hyperlipidemia or osteoarthritis. Interestingly, obese or morbidly obese patients without coronary heart disease were more likely to have obesity documented in the EMR problem list than obese or morbidly obese patients with coronary heart disease were.

###### 

Presence of obesity diagnosis in EMR problem list by comorbidities for obese patients (BMI ≥30 kg/m^2^).

![](10.1177_2055207620918715-table2)

  Comorbidity                Obesity diagnosis present in EMR problem list   Obesity diagnosis absent in EMR problem list   *p*
  -------------------------- ----------------------------------------------- ---------------------------------------------- -----
  *Coronary heart disease*   **\<0.0001**                                                                                   
   Yes                       410 (52%)                                       372 (48%)                                      
   No                        5679 (60%)                                      3747 (40%)                                     
  *Type II diabetes*         **\<0.0001**                                                                                   
   Yes                       1878 (64%)                                      1046 (36%)                                     
   No                        4211 (60%)                                      3073 (42%)                                     
  *Hyperlipidemia*           0.29                                                                                           
   Yes                       1573 (59%)                                      1102 (41%)                                     
   No                        4518 (60%)                                      3015 (40%)                                     
  *Hypertension*             **0.0004**                                                                                     
   Yes                       3814 (61%)                                      2436 (39%)                                     
   No                        2273 (58%)                                      1682 (42%)                                     
  *Osteoarthritis*           0.2                                                                                            
   Yes                       1084 (58%)                                      773 (42%)                                      
   No                        5005 (60%)                                      3346 (40%)                                     
  *Sleep apnea*              **\<0.0001**                                                                                   
   Yes                       366 (73%)                                       133 (27%)                                      
   No                        5723 (59%)                                      3986 (41%)                                     

Statistically significant values are shown in bold.

Discussion {#sec6-2055207620918715}
==========

The results of our assessment of EMRs of obese patients at our outpatient practice reveal several interesting findings. Underdiagnosis of obesity was clear, represented by 40% of all obese patients included. There was a clear demographic divide among our obese patient population in terms of receiving a diagnosis for obesity or not. Females, blacks, and younger patients were more likely to receive a diagnosis of obesity compared to obese males, whites, and older obese patients.

We found that patients with morbid obesity (class 3 obesity) were more likely to be diagnosed. These results indicate that providers may often wait until the health condition gets severe enough to warrant documentation in the EMR. Prevention, health education, and early treatment are all effective strategies for weight management, highlighting the need to recognize and address obesity at the early stage.^[@bibr30-2055207620918715][@bibr31-2055207620918715]--[@bibr32-2055207620918715]^

Early treatment is especially crucial in order to prevent the onset of several related comorbidities, such as coronary heart disease, type II diabetes, hypertension, hyperlipidemia, osteoarthritis, and sleep apnea. Long-term treatment of these associated chronic health conditions not only has a negative impact on the patient's physical health and quality of life, but also contributes to increased health-care costs for the patient.

In terms of associated comorbidities, some of the results are difficult to explain, particularly how a coronary heart disease diagnosis had an inverse association with the documentation of an obesity diagnosis, while obese patients with other conditions such as type II diabetes, hypertension, and sleep apnea were more likely to have obesity documented. It is possible that physicians associate these conditions more closely with obesity compared to coronary heart disease or hyperlipidemia.

It is also interesting to note that obese patients who were active users of the patient portal had more accurate and complete EMR problem lists, which was attributed to them being able to access their medical records routinely and cross-check for any inaccuracies. Our results are consistent with prior findings that highlight the relationship between patient access to their medical records and the accuracy and completeness of EMR problem lists.^[@bibr22-2055207620918715][@bibr23-2055207620918715]--[@bibr24-2055207620918715]^

Limitations {#sec7-2055207620918715}
-----------

There is still no consensus between experts regarding how to define and measure obesity properly.^[@bibr33-2055207620918715]^ While BMI is the accepted standard adopted by various national and international health organizations, it has been shown to suffer from various limitations, especially its use in population-wide studies of obesity, which may include individuals who are athletes or individuals with heights well below or above the population average.

Our results are representative of the diagnostic practices of physicians across outpatient clinics located primarily in a mid-size city and surrounding rural communities for an academic health system. Therefore, our findings may not be generalizable across other diverse health systems.

Finally, our study examines patient characteristics associated with obesity documentation in the EMR. To attain a better understanding of the reasons behind obesity underdiagnosis, it is also imperative to study physician-related factors that are motivators or barriers to documenting obesity in the EMR problem list.

Conclusion {#sec8-2055207620918715}
==========

Despite the Meaningful Use Stage 1 mandate for the recording and documentation of height, weight, blood pressure, and BMI as core measures of vital signs,^[@bibr34-2055207620918715]^ it is evident that this information is not being fully harnessed and applied in the delivery of health care. Automated techniques such as machine learning and natural language processing have been shown to be helpful for the automated inference of patient problems from structured EMR data.^[@bibr35-2055207620918715]^ EMR designers and developers must also consider the use of automated decision support techniques to populate and update problem lists by utilizing structured EMR data. Furthermore, larger-scale studies to analyze how EMR data can be used to predict patient populations that are more likely to be diagnosed with obesity may lead to new knowledge that could be incorporated in clinical decision support systems.

Further studies are recommended to investigate underlying causes of lower rates of obesity documentation for certain socio-demographic groups, and to study the impact of automated documentation. Similarly, further studies on physician-specific factors that play a role in the documentation of obesity in the EMR are recommended in order to provide a holistic view of the underdiagnosis problem.

Health-care providers must also continue patient engagement efforts and encourage patient portal use as a means of improving the quality of existing problem lists.
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